Industry buzz about MA Plans, Cures Act and ESRD Members

Get your "How MA Plans Can Get Ahead on Kidney Care" Executive Q&A.

Healthmap2021_CuresAct-QA.png

  BizED logo-color.png


Another powerful lineup this year

 



Healthmap2021_HCBizEd09-16_550x200.jpg


The 2022 open enrollment period begins in just a few weeks. This will be the second year under the Cures Act, allowing eligible end stage renal disease (ESRD) patients to once again have the opportunity to choose coverage under a Medicare Advantage (MA) plan.

Healthmap CEO and Co-Chair of the Board, Eric Reimer, shares what he and his team are hearing from MA plan clients as well as tips for MA plans seeking to scale and optimize their Cures Act kidney health management strategy.

Get your "How MA Plans Can Get Ahead on Kidney Care"
Executive Q&A

Currently, over 400,000 ESRD patients1 are eligible to enroll in an MA plan.  That population will continue to grow annually as over 100,0002 people are newly diagnosed with ESRD, at a cost of $80,000 to $100,0003 per person per plan year.

If your MA plan does not have a Cures Act strategy or has one
that is underperforming (or you don't know how it's performing),
now is the time to act
.

We are ready to work with your MA plan. Contact us to learn more about how Healthmap Solutions can help you achieve your kidney population management goals.

Tom Gaffney
Chief Growth Officer
Healthmap Solutions

Healthmap2021_CuresActQA.png
 
____________
1 United States Renal Data System. 2020 USRDS Annual Report: Epidemiology of kidney disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MA 2020. ADR Section D, Table D.21.
2 United States Renal Data System. 2020 USRDS Annual Data Report Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2020. Volume 2. Chapter 2. Table 1.1
3 United States Renal Data System. 2020 USRDS Annual Data Report Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2020.

 
 
 
Healthmap Solutions is an NCQA accredited Kidney Population Health Management company and an Affiliate Member of AHIP.
 

  NCQAPopH.png
  AHIP2021AO.png
 








                                          

HCBizEdReachHIPExecs500x90banner.png

HCBizEd05-20W500H90.png


Healthcare BizEducation (HCBizEd) is a service of
HCBD | www.hcbd.biz
team@hcbd.biz | 951-251-4223 | 686 Marlboro Rd, Lothian, MD 20711